Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL704369 | 0.79 | L3MBTL1 (0.47) | SIGMAR1L3MBTL1MAOAMAOBIDO1 | |
| SCHEMBL28660287 | 0.79 | TDP1 (0.35) | SIGMAR1 | |
| SCHEMBL6325312 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL19470822 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL3110910 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL19470840 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL19470846 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL19470849 | 0.78 | SIGMAR1 (0.48) | SIGMAR1L3MBTL1MAOAMAOB | |
| SCHEMBL2577645 | 0.77 | KCNA3 (0.55) | — | |
| SCHEMBL703456 | 0.76 | L3MBTL1 (0.44) | SIGMAR1L3MBTL1MAOAMAOBIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8049024-B2 | Heterogenized rhodium complexes, methods of their synthesis and application as hydrosilylation catalysts | ADAM MICKIEWICZ UNIVERSITY (PL) | 2011-11-01 | — | — | US | disclosed |
| US-20100048932-A1 | New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts | ADAM MICKIEWICZ UNIVERSITY (PL) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048932-A1 | New Heterogenized Rhodium Complexes, Methods of their Synthesis and Application as Hydrosilylation Catalysts | SQLE, HAO2, IPO11 | SIGMAR1 70/4885L3MBTL1 4346/4885MAOA 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.